Type 2 Diabetes & Metabolic Health Support
Advanced Umbilical Cord Mesenchymal Stem Cell Therapy Program for Type 2 Diabetes
This program is designed for people with type 2 diabetes whose long-term glucose control remains unsatisfactory, especially those struggling with insulin resistance and metabolic imbalance. Based on a comprehensive medical evaluation, the program combines physician-led umbilical cord mesenchymal stem cell therapy, continuous monitoring, medication optimization, and lifestyle management to help patients pursue more stable glucose control, improved metabolic balance, and a better quality of life.
- A more comprehensive metabolic solution that addresses underlying issues
- Helps reduce HbA1c and minimize glucose fluctuations
- Supports insulin sensitivity and pancreatic beta-cell function
- May help improve fatty liver, excess weight, and chronic inflammation
- Physician-led personalized care with close support throughout the process
Clinical Evidence & Case Study Section
“Real Results: How a 58-Year-Old Patient Regained Metabolic Control.” See the data for yourself. After struggling with a 10-year history of Type 2 Diabetes, high insulin dependency, and chronic post-meal fatigue, this patient underwent our integrated management pathway. Within months, continuous monitoring showed a stabilized, dramatic drop in HbA1c, significantly reduced insulin reliance, and a profound return of daily energy and stamina.
Evidence-Based Support
Clinical studies and meta-analyses suggest that mesenchymal stem cells may offer meaningful benefits in the management of type 2 diabetes, including restoring toward improved HbA1c, better pancreatic function, and a more favorable inflammatory profile. In our program, stem cell therapy is positioned as part of a physician-led metabolic support strategy rather than a standalone cure-size-fits-all promise
- Zhang L., et al. Stem Cell Research & Therapy. 2022;13:160.
- Li Y., et al. Stem Cell Research & Therapy. 2020;11:273.
- Mathur A., et al. Diabetes, Metabolic Syndrome and Obesity. 2023.
- ClinicalTrials.gov. Mesenchymal Stem Cells for Type 2 Diabetes.
Typical Case: Male, 58 Years Old
History: More than 10 years of disease history. Long-term oral anti-diabetic therapy plus basal insulin.
Condition Before Treatment: Before treatment, HbA1c was 8.6%, with marked glucose fluctuations and elevated post-meal blood sugar, together with fatty liver, hyperuricemia, and mild hypertension.
The Pathway: After physician evaluation, he entered an integrated management pathway including stem cell therapy support, CGM monitoring, medication adjustment, and lifestyle optimization.
Observed Trends in This Case
| Indicator | Pre-Treatment vs. Post-Treatment Result |
| HbA1c | 8.6% ➡️ downward trend by 3 months; stabilized around 6.9%–7.3% by 6–12 months |
| Fasting Glucose | ~9.2 mmol/L ➡️ often maintained around 7–8 mmol/L |
| Post-Meal Glucose | >13 mmol/L after meals ➡️ lower post-meal peaks |
| Basal Insulin | ~28 units/day ➡️ gradually reduced under physician supervision |
| Body Weight / Waistline | BMI 29.1, waist 101 cm ➡️ improving trend |
| Fatty Liver Indicators | Elevated ➡️ improvement trend |
| Quality of Life | Post-meal fatigue and poor stamina ➡️ improved energy |
Benefits & Highlights
More Than Blood Sugar Control
- Supports a healthier metabolic environment
- Improves the chance of achieving more stable long-term glucose control
- Helps reduce metabolic burden under physician supervision
- Integrates lifestyle guidance, medication adjustment, and cellular therapy support
- Supports overall metabolic health and wellbeing
Program Highlights
- Comprehensive endocrinology and metabolic assessment
- Advanced testing including blood glucose, HbA1c, fasting insulin, C-peptide, and related markers
- Liver and kidney function, coagulation profile, and infection screening
- Continuous Glucose Monitoring (CGM)
- Physician-led umbilical cord mesenchymal stem cell therapy (personalized protocol)
- 3-, 6-, and 12-month follow-up for long-term support
Treatment Pathway
Week 1
Initial evaluation and safety screening
01
Week 4
Advanced assessment + CGM monitoring initiated
02
Week 8
Personalized umbilical cord mesenchymal stem cell therapy begins
03
Week 12
3-month review and assessment
04
Week 24
6-month review and assessment
05
Week 48
12-month summary and ongoing management
06
A Premium Approach To Metabolic Wellness Support
This program is positioned as a high-value wellness option for clients seeking advanced metabolic support beyond routine medication management and standard lifestyle advice.
Non-Surgical Support
Premium Metabolic Health Experience
Personalized Wellness Planning
Long-Term Health Focused Care
Physician-Led • Hospital-Based • Personalized Management
Frequently Asked Questions (FAQ)
1.What is metabolic wellness support?
Metabolic wellness programs focus on supporting blood sugar balance, inflammation wellness, and long-term metabolic health under professional medical guidance.
2. Does this replace diabetes medication?
No. This program is designed as supportive wellness care and does not replace standard diabetes treatment or prescribed medication.
3. Who may benefit from this program?
Clients with type 2 diabetes, insulin resistance, metabolic syndrome, or long-term blood sugar management concerns may consider this program after medical consultation.
4. What tests may be included in the program?
Programs may include HbA1c testing, glucose monitoring, liver and kidney function tests, and metabolic marker evaluation.
5. Is the program physician supervised?
Yes. All wellness recommendations and regenerative support planning are conducted under professional medical supervision.
Start Your Metabolic Wellness Journey
Some patients may benefit from a more structured and comprehensive strategy — not simply more medication.